Antifungal alternatives for invasive candidiasis refractory to caspofungin in liver transplant recipients: A report of two cases [2]

Transplantation

Volumn 82, Issue 10, 2006, Pages 1385-1386

  Choukroun, Gérald ^a   Thirion, Marina ^a   Lortholary, Olivier ^b,c   Scatton, Olivier ^a   Conti, Filomena ^a   Calmus, Yvon ^a   Paugam, André ^a   Pène, Frédéric ^a  

^a University Paris Descartes ^*  (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; CORTICOSTEROID; FLUCYTOSINE; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TSUKUBAENOLIDE;

CANDIDIASIS; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG ASPERGILLOSIS; LUNG TRANSPLANTATION; PRIORITY JOURNAL; RETRANSPLANTATION;

ADOLESCENT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REOPERATION;

EID: 33751518109     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000235988.51610.f7     Document Type: Letter

References (6)

1. Cuenca-Estrella M, Moore CB, Barchiesi F, et al. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect 2003; 9(6): 467.
2. Pfaller MA, Diekema DJ, Boyken L, et al. Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole. J Clin Microbiol 2003; 41(5): 1875.
3. Pfaller MA, Boyken L, Hollis RJ, et al. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance. J Clin Microbiol 2006; 44(3): 760.
4. Krogh-Madsen M, Arendrup MC, Heslet L, Knudsen JD. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis 2006; 42(7): 938.
5. Pfaller MA, Diekema DJ, Messer SA, et al. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol 2003; 41(1): 78.
6. Dannaoui E, Lortholary O, Dromer F. In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother 2004; 48(3): 970.